Levodropropizine

DRUG4 trials

Sponsors

Fakultni Nemocnice Hradec Kralove, Hanmi Pharmaceutical Company Limited, University Hospital Hradec Kralove, Pontificia Universidad Catolica de Chile

Conditions

DyspneaHealthyUpper Resp Tract Infectiondyspnea perception in patients with advanced lung disease

Phase 1

A Drug-Drug Interaction Study of Ambroxol and Levodropropizine

CompletedNCT01573663

Hanmi Pharmaceutical Company LimitedHealthy

Start: 2012-02-29End: 2012-04-30Updated: 2012-07-19

Phase 2

The Impact of Inhaled Furosemide and Perorally Administered Levodropropizine on Dyspnea in Patients With Respiratory Diseases

RecruitingNCT06252454

University Hospital Hradec KraloveDyspnea

Start: 2024-02-27End: 2025-12-31Target: 102Updated: 2024-04-16

The Impact of Inhaled Furosemide and Perorally Administered Levodropropizine on Dyspnea in Patients With Advanced Respiratory Diseases (INFURO)

RecruitingCTIS2024-514672-41-00

Fakultni Nemocnice Hradec Kralovedyspnea perception in patients with advanced lung disease

Start: 2024-02-27Target: 114Updated: 2025-11-13

Phase 4

CHAO Tos: Codeina, HederA Helix, LevOdropropizina Para la TOS

CompletedNCT06907355

Pontificia Universidad Catolica de ChileUpper Resp Tract Infection

Start: 2025-05-13End: 2025-12-01Updated: 2025-12-03